About Pipeline Publications News Media Investors Contact

2 December 2025

House passes bill that reauthorises the FDA's paediatric priority voucher pathway

ilyaPharma

Developing local-acting immunotherapies with live, non-colonising lactic acid bacteria acting as mini-bioreactors in skin and mucosa.

Explore

About
Pipeline
Publications
News
Media
Investors
Contact

Contact

Ilya Pharma AB (publ)

Rapsgatan 7E, 754 50 Uppsala, Sweden

info@ilyapharma.se

© 2026 Ilya Pharma AB. Org.nr 559062-6015

Privacy & cookies Admin